Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -2024202320222021202020192018201720162015 21 November 2016 Disclosure of Outstanding Voting Securities Regulated information 17 November 2016 Thermo Fisher Scientific to Distribute Biocartis’ Idylla™ Automated Molecular Diagnostics Testing Platform in U.S. Inside information Regulated information 17 November 2016 Biocartis Q3 2016 Business Update Regulated information 31 October 2016 Biocartis receives EUR 1.4m grant to support development of its rapid NGS Prep Panels Non-regulated information 18 October 2016 Biocartis receives EUR 2.5m strategic grant from Flemish government to support manufacturing capacity expansion Minister Muyters, Flemish Minister of Work, Economy, Innovation and Sports visits Biocartis on 18 October 2016 to announce the grant Non-regulated information 11 October 2016 AstraZeneca Comparative Study confirms Best-In-Class Status of Idylla™ KRAS Mutation Detection Technology Non-regulated information 7 October 2016 Three Idylla™ Test Performance Studies to be presented at Esmo Oncology Conference Non-regulated information 6 September 2016 Biocartis Announces H1 2016 Results Regulated information 30 August 2016 Biocartis announces 2016 Half-Year Results on 6 September 2016 Regulated information 20 July 2016 Biocartis Attracts EUR 55 Million Non-dilutive Financing Regulated information Pagination First page « First Previous page ‹‹ … Page 23 Page 24 Page 25 Page 26 Page 27 Current page 28 Page 29 Page 30 Page 31 Next page ›› Last page Last »